BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells

Debalina Sarkar, Brian Shields, Melanie L. Davies, Jürgen Müller, Jane A. Wakeman*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Cancer stem cells (CSCs) are initiating cells in colorectal cancer (CRC). Colorectal tumours undergo epithelial to mesenchymal transition (EMT)-like processes at the invasive front, enabling invasion and metastasis, and recent studies have linked this process to the acquisition of stem cell-like properties. It is of fundamental importance to understand the molecular events leading to the establishment of cancer initiating cells and how these mechanisms relate to cellular transitions during tumourigenesis. We use an in vitro system to recapitulate changes in CRC cells at the invasive front (mesenchymal-like cells) and central mass (epithelial-like cells) of tumours. We show that the mesoderm inducer BRACHYURY is expressed in a subpopulation of CRC cells that resemble invasive front mesenchymal-like cells, where it acts to impose characteristics of CSCs in a fully reversible manner, suggesting reversible formation and modulation of such cells. BRACHYURY, itself regulated by the oncogene β-catenin, influences NANOG and other 'stemness' markers including a panel of markers defining CRC-CSC whose presence has been linked to poor patient prognosis. Similar regulation of NANOG through BRACHYURY was observed in other cells lines, suggesting this might be a pathway common to cancer cells undergoing mesenchymal transition. We suggest that BRACHYURY may regulate NANOG in mesenchymal-like CRC cells to impose a 'plastic-state', allowing competence of cells to respond to signals prompting invasion or metastasis.

Original languageEnglish
Pages (from-to)328-337
Number of pages10
JournalInternational Journal of Cancer
Volume130
Issue number2
Early online date28 May 2011
DOIs
Publication statusPublished - 15 Jan 2012

Fingerprint

Neoplastic Stem Cells
Colorectal Neoplasms
Neoplasm Metastasis
Catenins
Neoplasms
Epithelial-Mesenchymal Transition
Mesoderm
Oncogenes
Mental Competency
Plastics
Stem Cells
Epithelial Cells
Cell Line

Keywords

  • Brachyury
  • cancer stem cells
  • colorectal cancer
  • Nanog

Cite this

Sarkar, D., Shields, B., Davies, M. L., Müller, J., & Wakeman, J. A. (2012). BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. International Journal of Cancer, 130(2), 328-337. https://doi.org/10.1002/ijc.26029
Sarkar, Debalina ; Shields, Brian ; Davies, Melanie L. ; Müller, Jürgen ; Wakeman, Jane A. / BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. In: International Journal of Cancer. 2012 ; Vol. 130, No. 2. pp. 328-337.
@article{6d7f1b49583648da927d7ca8ef295416,
title = "BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells",
abstract = "Cancer stem cells (CSCs) are initiating cells in colorectal cancer (CRC). Colorectal tumours undergo epithelial to mesenchymal transition (EMT)-like processes at the invasive front, enabling invasion and metastasis, and recent studies have linked this process to the acquisition of stem cell-like properties. It is of fundamental importance to understand the molecular events leading to the establishment of cancer initiating cells and how these mechanisms relate to cellular transitions during tumourigenesis. We use an in vitro system to recapitulate changes in CRC cells at the invasive front (mesenchymal-like cells) and central mass (epithelial-like cells) of tumours. We show that the mesoderm inducer BRACHYURY is expressed in a subpopulation of CRC cells that resemble invasive front mesenchymal-like cells, where it acts to impose characteristics of CSCs in a fully reversible manner, suggesting reversible formation and modulation of such cells. BRACHYURY, itself regulated by the oncogene β-catenin, influences NANOG and other 'stemness' markers including a panel of markers defining CRC-CSC whose presence has been linked to poor patient prognosis. Similar regulation of NANOG through BRACHYURY was observed in other cells lines, suggesting this might be a pathway common to cancer cells undergoing mesenchymal transition. We suggest that BRACHYURY may regulate NANOG in mesenchymal-like CRC cells to impose a 'plastic-state', allowing competence of cells to respond to signals prompting invasion or metastasis.",
keywords = "Brachyury, cancer stem cells, colorectal cancer, Nanog",
author = "Debalina Sarkar and Brian Shields and Davies, {Melanie L.} and J{\"u}rgen M{\"u}ller and Wakeman, {Jane A.}",
year = "2012",
month = "1",
day = "15",
doi = "10.1002/ijc.26029",
language = "English",
volume = "130",
pages = "328--337",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

Sarkar, D, Shields, B, Davies, ML, Müller, J & Wakeman, JA 2012, 'BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells', International Journal of Cancer, vol. 130, no. 2, pp. 328-337. https://doi.org/10.1002/ijc.26029

BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. / Sarkar, Debalina; Shields, Brian; Davies, Melanie L.; Müller, Jürgen; Wakeman, Jane A.

In: International Journal of Cancer, Vol. 130, No. 2, 15.01.2012, p. 328-337.

Research output: Contribution to journalArticle

TY - JOUR

T1 - BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells

AU - Sarkar, Debalina

AU - Shields, Brian

AU - Davies, Melanie L.

AU - Müller, Jürgen

AU - Wakeman, Jane A.

PY - 2012/1/15

Y1 - 2012/1/15

N2 - Cancer stem cells (CSCs) are initiating cells in colorectal cancer (CRC). Colorectal tumours undergo epithelial to mesenchymal transition (EMT)-like processes at the invasive front, enabling invasion and metastasis, and recent studies have linked this process to the acquisition of stem cell-like properties. It is of fundamental importance to understand the molecular events leading to the establishment of cancer initiating cells and how these mechanisms relate to cellular transitions during tumourigenesis. We use an in vitro system to recapitulate changes in CRC cells at the invasive front (mesenchymal-like cells) and central mass (epithelial-like cells) of tumours. We show that the mesoderm inducer BRACHYURY is expressed in a subpopulation of CRC cells that resemble invasive front mesenchymal-like cells, where it acts to impose characteristics of CSCs in a fully reversible manner, suggesting reversible formation and modulation of such cells. BRACHYURY, itself regulated by the oncogene β-catenin, influences NANOG and other 'stemness' markers including a panel of markers defining CRC-CSC whose presence has been linked to poor patient prognosis. Similar regulation of NANOG through BRACHYURY was observed in other cells lines, suggesting this might be a pathway common to cancer cells undergoing mesenchymal transition. We suggest that BRACHYURY may regulate NANOG in mesenchymal-like CRC cells to impose a 'plastic-state', allowing competence of cells to respond to signals prompting invasion or metastasis.

AB - Cancer stem cells (CSCs) are initiating cells in colorectal cancer (CRC). Colorectal tumours undergo epithelial to mesenchymal transition (EMT)-like processes at the invasive front, enabling invasion and metastasis, and recent studies have linked this process to the acquisition of stem cell-like properties. It is of fundamental importance to understand the molecular events leading to the establishment of cancer initiating cells and how these mechanisms relate to cellular transitions during tumourigenesis. We use an in vitro system to recapitulate changes in CRC cells at the invasive front (mesenchymal-like cells) and central mass (epithelial-like cells) of tumours. We show that the mesoderm inducer BRACHYURY is expressed in a subpopulation of CRC cells that resemble invasive front mesenchymal-like cells, where it acts to impose characteristics of CSCs in a fully reversible manner, suggesting reversible formation and modulation of such cells. BRACHYURY, itself regulated by the oncogene β-catenin, influences NANOG and other 'stemness' markers including a panel of markers defining CRC-CSC whose presence has been linked to poor patient prognosis. Similar regulation of NANOG through BRACHYURY was observed in other cells lines, suggesting this might be a pathway common to cancer cells undergoing mesenchymal transition. We suggest that BRACHYURY may regulate NANOG in mesenchymal-like CRC cells to impose a 'plastic-state', allowing competence of cells to respond to signals prompting invasion or metastasis.

KW - Brachyury

KW - cancer stem cells

KW - colorectal cancer

KW - Nanog

UR - http://onlinelibrary.wiley.com/doi/10.1002/ijc.26029/abstract

UR - http://www.scopus.com/inward/record.url?scp=83655201491&partnerID=8YFLogxK

U2 - 10.1002/ijc.26029

DO - 10.1002/ijc.26029

M3 - Article

C2 - 21365650

AN - SCOPUS:83655201491

VL - 130

SP - 328

EP - 337

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -